The olloimrnunizotion rote of onti-c concurrent with onti-E in R1R1 potients.
- Author:
Hyun Ok KIM
;
Hyo Jun AHN
;
Yong Bin EOM
;
Jung Sin LEE
;
Min Ja CHOI
- Publication Type:Original Article
- MeSH:
Antibodies;
Blood Banks;
Blood Group Incompatibility;
Humans;
Incidence;
Infant, Newborn;
Phenotype
- From:Korean Journal of Blood Transfusion
1996;7(2):181-186
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Anti-E and anti-c is one of the clinical significant irregular antibodies developing a delayed hemolytic transfusion reaction and hemolytic disease of the newborn. Since anti-c occurs frequently with anti-E in immunized people whosoe cells are E-and c-, it has been recommended to select blood of the patient's own R1 phenotype for transfusion, even when the presence of anti-c cannot be demonstrated in his/her serum. To determine the utility of this approach, we reviewed the blood bank laboratory records of patients identified anti-E and anti-c in his/her serum in Severance hospital over a 12 year period (1985-1996). During the 12-year period of study, 53 patients were identified with anti-E and/or anti-c; 30(56.6%) patients had anti-E alone, 6(11.3%) had anti-c, and 17(32.1%) had both. Thirty eight of forty two patients whose Rh-hr phenotypes were tested were R1R1. Of these 38 R1R1 patients, 16 patients (42.1%) presented with anti-c concomitant with anti-E. Ouru study showed that the incidence of antni-c in R1R1 patients with anti-E is similar to that of studies reported in Caucasian groups. We highly suggest the transfusion protocol of prophylactic use of c negative blood for R1R1 patients with anti-E. Furthermore, because anti-c may be present in concentrations too low to be detected, the enzyme technique is recommended in parallel with standard serologic methods for the identification of irregular antibodies.
